Kinetic and thermodynamic studies of 9-aminocamptothecin hydrolysis at physiological pH in the presence of human serum albumin

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 5, 2013, Pages 858-863

  Patel, Deval ^a   Rahman, Shahidur ^a   Savva, Michalakis ^a  

^a LONG ISLAND UNIVERSITY   (United States)

Author keywords

9 Aminocamptothecin; Derivative spectrophotometry; Hydrolysis kinetics; Protein binding; Thermodynamics

Indexed keywords

9 AMINOCAMPTOTHECIN; CAMPTOTHECIN; CARBOXYLIC ACID; FIRTECAN; HUMAN SERUM ALBUMIN; LACTONE;

ABSORPTION SPECTROPHOTOMETRY; ARTICLE; ENERGY; ENTHALPY; ENTROPY; HYDROLYSIS; KINETICS; PH; PRIORITY JOURNAL; THERMODYNAMICS;

EID: 84885050203     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.06.005     Document Type: Article

References (28)

1. Bartlett, N.L., Johnson, J.L., Wagner-Johnston, N., Ratain, M.J., Peterson, B.A., 2009. Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of cancer and leukemia group B 9551. Cancer Chemother. Pharmacol. 63, 793-798.
2. Bjornsti, M.A., Benedetti, P., Viglianti, G.A., Wang, J.C., 1989. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49, 6318-6323. (Pubitemid 20000930)
3. Burke, T.G., Mi, Z., 1994. The structural basis of camptothecin interactions with Human serum albumin: impact of drug stability. J. Med. Chem. 37, 40-46. (Pubitemid 24058811)
4. Burke, T.G., Mi, Z., 1993. Preferential binding of the carboxylate form of camptothecin by human serum albumin. Anal. Biochem. 212, 285-287. (Pubitemid 23219487)
5. Burke, T.G., Mishra, A.K., Wani, M.C., Wall, M.E., 1993. Lipid bilayer partitioning and stability of camptothecin drugs. Biochemistry 32, 5352-5364. (Pubitemid 23167976)
6. Dufour, C., Dangles, O., 2005. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochim. Biophys. Acta. 1721, 164-173. (Pubitemid 40093524)
7. Garcia-Carbonero, R., Supko, J.G., 2002. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin. Cancer Res. 8, 641-661. (Pubitemid 34742090)
8. Gentry, A.C., Juul, S., Veigaard, C., Knudsen, B.R., Osheroff, N., 2011. The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I. Nucleic Acids Res. 39, 1014-1022.
9. Hertzberg, R.P., Caranfa, M.J., Hecht, S.M., 1989. On the mechanism of Topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 28, 4629-4638. (Pubitemid 19151036)
10. Hochster, H., Plimack, E.R., Runowicz, C.D., Speyer, J., Wallach, R.C., Sorich, J., Mandeli, J., Wadler, S., Wright, J., Muggia, F.M., 2004. Biweekly 72-h 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York gynecologic oncology group and the Eastern cooperative oncology group. J. Clin. Oncol. 22, 120-126. (Pubitemid 41095123)
11. Hsiang, Y.H., Lihou, M.G., Liu, L.F., 1989. Arrest of replication forks by drugstabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49, 5077-5082. (Pubitemid 19239347)
12. Kratochwil, N.A., Huber, W., Muller, F., Kansy, M., Gerber, P.R., 2002. Predicting plasma protein binding of drugs: a new approach. Biochem. Pharmacol. 64, 1355-1374. (Pubitemid 35248253)
13. Kunadharaju, S., Savva, M., 2008. Kinetic and thermodynamic analysis of 10-hydroxy-camptothecin hydrolysis at physiological pH. J. Chem. Therm. 40, 1439-1444.
14. Leguizamo, J., Quinn, M., Takimoto, C.H., Liang, M.D., Ismail Abdel-Salam, A., Pang, J., Dahut, W., Grem, J.L., 2003. A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion. Cancer Chemother. Pharmacol. 52, 333-338. (Pubitemid 37352600)
15. Mi, Z., Burke, T.G., 1994. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry 33, 10325-10336. (Pubitemid 24281798)
16. Miller, D.S., Blessing, J.A., Waggoner, S., Schilder, J., Sorosky, J., Bloss, J., Schilder, R., 2005. Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: a gynecologic oncology group study. Gynecol. Oncol. 96, 67-71. (Pubitemid 39612419)
17. Pommier, Y., 2013. Drugging topoisomerases: lessons and challenges. ACS Chem. Biol. 8, 82-95.
18. Pommier, Y., 2009. DNA Topoisomerase I inhibitors: chemistry, biology and interfacial inhibition. Chem. Rev. 109, 2894-2902.
19. Pommier, Y., 2006. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6, 789-802. (Pubitemid 44450467)
20. Saha, S.C., Kunadharaju, S., Sivakumar, B., Savva, M., 2010. Kinetic and thermodynamic analysis of 9-nitro-camptothecin hydrolysis at physiological pH in the presence and absence of human serum albumin. Int. J. Chem. Kinet. 42, 693-703.
21. Sasnouski, S., Zorin, V., Khludeyev, I., D'Hallewin, M.A., Guillemin, F., Bezdetnaya, L., 2005. Investigation of foscan (R) interactions with plasma proteins. Biochim. Biophys. Acta. 1725, 394-402. (Pubitemid 41393535)
22. Selvi, B., Patel, S., Savva, M., 2008. Physicochemical characterization and membrane binding properties of camptothecin. J. Pharm. Sci. 97, 4379-4390.
23. Sivakumar, B., Thakur, R., Kunadharaju, S., Savva, M., 2011. Thermodynamic studies of SN38 hydrolysis in the presence of human and bovine serum albumin. Curr. Phys. Chem. 1, 140-151.
24. Thakur, R., Kunadharaju, S., Savva, M., 2009. Kinetic and thermodynamic characterization of camptothecin hydrolysis at physiological pH in the absence and presence of human serum albumin. Int. J. Chem. Kinet. 41, 704-715.
25. Thomas, R.R., Dahut, W., Harold, N., et al., 2001. A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients. Cancer Chemother. Pharmacol. 48, 215-222. (Pubitemid 32758896)
26. Ulukan, H., Swaan, P.W., 2002. Camptothecins: a review of their chemotherapeutic potential. Drugs 62, 2039-2057. (Pubitemid 35204037)
27. Venditto, V.J., Simanek, E.E., 2010. Cancer therapies utilizing the camptothecins: a review of the in vivo literature. Mol. Pharm. 7, 307-349.
28. Wani, M.C., Nicholas, A.W., Wall, M.E., 1986. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues. J. Med. Chem. 29, 2358-2363. (Pubitemid 17182317)